AU4478200A - Death domain containing receptors - Google Patents
Death domain containing receptorsInfo
- Publication number
- AU4478200A AU4478200A AU44782/00A AU4478200A AU4478200A AU 4478200 A AU4478200 A AU 4478200A AU 44782/00 A AU44782/00 A AU 44782/00A AU 4478200 A AU4478200 A AU 4478200A AU 4478200 A AU4478200 A AU 4478200A
- Authority
- AU
- Australia
- Prior art keywords
- domain containing
- death domain
- containing receptors
- receptors
- death
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4747—Apoptosis related proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2878—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Transplantation (AREA)
- Cell Biology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13048899P | 1999-04-22 | 1999-04-22 | |
US60130488 | 1999-04-22 | ||
US13674199P | 1999-05-28 | 1999-05-28 | |
US60136741 | 1999-05-28 | ||
PCT/US2000/010741 WO2000064465A1 (en) | 1999-04-22 | 2000-04-21 | Death domain containing receptors |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4478200A true AU4478200A (en) | 2000-11-10 |
Family
ID=26828526
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU44782/00A Abandoned AU4478200A (en) | 1999-04-22 | 2000-04-21 | Death domain containing receptors |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1178815A4 (de) |
JP (1) | JP2003522118A (de) |
AU (1) | AU4478200A (de) |
CA (1) | CA2371114A1 (de) |
WO (1) | WO2000064465A1 (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6469144B1 (en) | 1996-04-01 | 2002-10-22 | Genentech, Inc. | Apo-2LI and Apo-3 polypeptides |
US6462176B1 (en) | 1996-09-23 | 2002-10-08 | Genentech, Inc. | Apo-3 polypeptide |
JP2003514031A (ja) * | 1999-11-19 | 2003-04-15 | トーマス ブイ. ティットル, | Tr3特異的結合剤およびその使用のための方法 |
US6994976B1 (en) | 1999-11-19 | 2006-02-07 | Tittle Thomas V | Tr3-specific binding agents and methods for their use |
WO2003013581A1 (en) * | 2001-08-03 | 2003-02-20 | Genset S.A. | Agonists and antagonists of genceptin for the treatment of metabolic disorders |
EP1361433A3 (de) * | 2002-04-09 | 2005-02-23 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Verfahren zur erkennung die therapeutisches Wirkung TNF |
DK1667730T3 (da) * | 2003-08-20 | 2013-09-23 | Univ Miami | Sammensætninger og fremgangsmåder til behandling af inflammatorisk lungesygdom |
CA2590461A1 (en) * | 2004-12-23 | 2006-06-29 | Laboratoires Serono S.A. | Bcma polypeptides and uses thereof |
ES2611307T3 (es) | 2005-08-30 | 2017-05-08 | University Of Miami | Inmunomodulación de agonistas, antagonistas e inmunotoxinas del receptor del factor de necrosis tumoral 25 (TNFR25) |
EP2462165B1 (de) | 2009-08-03 | 2016-05-11 | University of Miami | Verfahren zur in-vivo-expansion regulatorischer t-zellen |
WO2012117067A1 (en) | 2011-03-01 | 2012-09-07 | Novo Nordisk A/S | Antagonistic dr3 ligands |
JP2016504045A (ja) | 2013-01-09 | 2016-02-12 | ザ ユニバーシティー オブ マイアミThe University Of Miami | TL1A−Ig融合タンパク質を用いる制御性T細胞の制御のための組成物及び方法 |
EP3126396A4 (de) * | 2014-04-04 | 2017-09-06 | Kyowa Hakko Kirin Co., Ltd. | Antagonistische anti-death-rezeptor 3 (dr3)-antikörper mit verringerter agonistischer aktivität |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4179337A (en) * | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
US5120525A (en) * | 1988-03-29 | 1992-06-09 | Immunomedics, Inc. | Radiolabeled antibody cytotoxic therapy of cancer |
US5656272A (en) * | 1991-03-18 | 1997-08-12 | New York University Medical Center | Methods of treating TNF-α-mediated Crohn's disease using chimeric anti-TNF antibodies |
WO1997033904A1 (en) * | 1996-03-12 | 1997-09-18 | Human Genome Sciences, Inc. | Death domain containing receptors |
US6469144B1 (en) * | 1996-04-01 | 2002-10-22 | Genentech, Inc. | Apo-2LI and Apo-3 polypeptides |
PT1012274E (pt) * | 1997-01-28 | 2007-08-14 | Craig A Rosen | Receptor 4 contendo um domínio de morte (dm4; receptor de morte 4), membro da super-família do ftn e ligação a liart (ap02) |
-
2000
- 2000-04-21 EP EP00926218A patent/EP1178815A4/de not_active Withdrawn
- 2000-04-21 JP JP2000613455A patent/JP2003522118A/ja not_active Withdrawn
- 2000-04-21 AU AU44782/00A patent/AU4478200A/en not_active Abandoned
- 2000-04-21 CA CA002371114A patent/CA2371114A1/en not_active Abandoned
- 2000-04-21 WO PCT/US2000/010741 patent/WO2000064465A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1178815A1 (de) | 2002-02-13 |
CA2371114A1 (en) | 2000-11-02 |
WO2000064465A1 (en) | 2000-11-02 |
JP2003522118A (ja) | 2003-07-22 |
EP1178815A4 (de) | 2003-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5546000A (en) | Compounds | |
AU4817200A (en) | Death domain containing receptor 5 | |
AU5633300A (en) | Indole compounds | |
AU4478200A (en) | Death domain containing receptors | |
AU4984300A (en) | Death domain containing receptor 4 | |
AU1746401A (en) | Compounds | |
AU3997700A (en) | Anti-first-pass effect compounds | |
AU6032100A (en) | New compounds | |
AU4807300A (en) | Dispenser cover | |
AU6050500A (en) | Benzothiophene derivatives | |
AU2676001A (en) | Fire-protection device | |
AU3543599A (en) | Receptors | |
AU2002217962A1 (en) | Death domain proteins | |
AU5633800A (en) | Indole compounds | |
AUPQ078799A0 (en) | New use | |
AU2669501A (en) | New use | |
AU1202701A (en) | Domain name searching | |
AU2702800A (en) | Multiple-package sleeve container | |
AU6567400A (en) | Substituted 2-imino-thiazolines | |
AU3809500A (en) | Expression | |
AU6614000A (en) | Chimeric receptors and their uses | |
AU5119400A (en) | Compounds | |
AU3158701A (en) | New use | |
AU6831100A (en) | Substituted heterocyclybenzofuranes | |
AU6168900A (en) | Compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |